• Ciencia e Innovación en Salud adheres to the prevailing industry standards and procedures for investigating publication ethics.
  • Ciencia e Innovación en Salud not allow dual publication (the same material published twice in the peer reviewed literature), or dual submission (the same material simultaneously submitted to more than one journal).
  • Ciencia e Innovación en Salud does not tolerate plagiarism, data or figure manipulation, knowingly providing incorrect information, copyright infringement, inaccurate author attributions, attempts to inappropriately manipulate the peer review process, failures to declare conflicts of interest, fraud, and libel. The journal follows the rules of the Committee on Publication Ethic (COPE) and the World Association of Medical Editors (WAME), among others.
  • In extreme cases, this may call for individuals to be reported to their institutions and/or for manuscripts to be retracted. Any complaints should be directed to editorial.support@revcis.com 

 

Committee on Publication Ethics (COPE)

Ciencia e Innovación en Salud adheres to the COPE Code of Conduct and Best Practice Guidelines. We follow recommended COPE procedures whenever we are alerted to an issue which requires investigation.

 

Ethics Statement

  1. Where applicable, Ciencia e Innovación en Salud requires that authors provide an Ethics statement which details the relevant ethical standards which were met when conducting the research.
  2. Ethics statements are required whenever research is conducted on humans or human tissue; on animals or animal tissue; when conducting field studies; or whenever the approval of an Institutional Review Board (IRB) or Institutional Ethics Committee (ERC) was required.
  3. In addition to providing an Ethics statement upon submission (for review purposes), this same statement should also be provided in the Materials and Methods section of the manuscript.
  4. Where IRB or ERC approval was required, the authors must provide an ethics statement as part of their Materials and Methods section detailing full information regarding their approval (including the name of the granting organization, and the approval reference numbers).?? If an approval reference number is not provided, written approval must be provided as confidential supplemental file.

 

Author Duties

The Corresponding Author’s Role and Responsibilities are to:

  1. Inform all co-authors of the submission of the manuscript to the journal (note: each co-author must sign the presentation or cover letter and confirm their authorship).
  2. Ensure that the manuscript is in full adherence to all Health Science and Innovation policies. Additionally ensure that all co-authors are aware of, and in compliance with all of them.
  3. Manage all correspondence between the journal and all co-authors, keeping the full co-authors group apprised of the manuscript progress.
  4. Designate a substitute correspondent for times of unavailability
  5. Ensure to fill out all required points at the time of submission of the manuscript.
  6. Post-publication: respond to all queries pertaining to the published manuscript, provide all data and requested materials.
  7. The submission must be created (and completed) by one of the co-authors, not by an agency or by some other individual who is not one of the co-authors

 

Reviewer and Editor Blinding

  1. Authors may request that specific individuals be prevented from seeing their submission (a practice known as 'blinding').
  2. Requests to blind individuals should be limited in nature, should refer to specific individuals (not broad lists or categories of people), and should be made only with good reason.
  3. While we will attempt to honor these requests, we cannot guarantee that all requests will be honored.

 

Confidentiality

Ciencia e Innovación en Salud keeps all details about a submitted manuscript confidential, does not publicly comment about submitted or rejected manuscripts and maintains reviewer confidentiality unless given permission to reveal identities. Authors, reviewers and editors must also treat correspondence as confidential unless explicitly stated otherwise.